This study was conducted to estimate the frequency of BRCA1 (185delAG) mutation among Egyptian female patients with breast cancer. Forty selected female patients with breast cancer, 80 of their female relatives and 10 healthy females as a control group were included in this study. Result: The age of onset of breast cancer was below 40 years in 25 (62.5%) patients and above 40 years in 15 (37.5%) patients. There were significant differences among the patients regarding the age at menarche before 13 years (p=0.011, p<0.05), onset of breast cancer (p=0.000, p<0.001), parity (p=0.000, p<0.001), first delivery before 30 years of age (p=0.04, p<0.05), breast feeding (p=0.002, p<0.05), and positive family history (p=0.000, p<0.001). The frequency of BRCA1 (185delAG) mutation was found among 10% of the patients' group. Eight percent of patients with early onset below 40 years and 13.5% of patients with onset after 40 years were heterozygotes for the mutation. Three percent of patients with unilateral breast cancer, 40% of patients with bilateral breast cancer and 50% of patients with breast ovarian cancer were carrying the mutation. Our results indicated that breast ovarian cancer and bilateral breast cancer patients were likely to have BRCA1 (185delAG) mutation than in unilateral breast cancer.
INTRODUCTION
Breast cancer (BC) is the most common malignancy in women, accounting for 31% of all female cancers, and responsible for 15% of cancer deaths in women. (1) One million females world wide are diagnosed with BC every year. Treatment of advanced BC is futile and disfiguring, making early detection has a high priority in medical management of the disease. (2) The risk factors of BC include genetic, environmental, and hormonal. Genetic risk factors contribute to about 5%-10% of all cases, 90%-95% of them result from somatic mutation and about 5%-10% are inherited as the result of germ line mutation in autosomal dominant BC susceptibility genes. (3, 4) Many genes have been found to increase susceptibility to cancer and are also associated with familial breast cancer.
These genes include Breast Cancer Anti- 
PATIENTS AND METHODS

RESULTS
This study included 40 female patients
with BC or BOC, 80 of their close female relatives and 10 healthy adult females as a control group.
Characteristics of cases
The age of menarche was below 13 years in 28 patients (70%) and over 13 years in 12 patients (30%) with a mean age of 13.20±1.3 years .The age of menopause was more than 45 years in 8 patients (20%) with a mean age of 49.10±3.4 years.
The remaining 32 patients (80%) did not experience menopause as they developed cancer at young age. The majority of the patients, 37 cases (92.5%), were married.
Nullipara constituted 6 patients (15%).
Among 34 patients (85%); 23 (67.6%) had their 1 st child below 30 years of age while 11 (32.4%) were over 30 years. Breast feeding was practiced in 30 patients (75%). 
Classification of cases
The female patients were classified into 2 groups according to the age of onset of the disease. ( Table 2) Molecular study DNA was amplified using intronic specific primers spanning exon 2 (262bp).
Similar amplified PCR products for all samples subjected to the present study were detected (Fig. 1 ).
The SSCP analysis revealed 4 patients (10%) carring 185 del AG mutation in BRCA1 gene. (Fig. 2 and 3) . No mutation was detected in the patient's relatives or in control groups.
The main findings of the four patients with BRCA1 mutation are summarized in (Table   3) . This low risk of BC in parous women might result from the protective effect of age at first pregnancy and child birth. (16) (17) (18) The finding of the present study was contrary to that as parous women were significantly higher in the patients group (P<0.05).
These parous women may be exposed to a strong risk factors that lead to the BC inspite of the protective effect of parity.
Late age at first child birth increases the life time incidence of BC. (19, 20) It was reported that being older than 30 years at first delivery is a risk factor for BC. (21) The highest risk was in those who have a first child after the age of 35 years, they appear to be at even a higher risk than that of nulliparous women. (22) Moreover, epidemiological studies have consistently shown that women who undergo an early first full term pregnancy have a significantly reduced life time risk of BC, this association is independent of parity, i.e., number of live birth. (19, 20) In the present study there was no significant difference in age at first delivery between parous patients and controls, moreover, the parous patients who gave birth to their first child before 30 years of age were significantly higher (P<0.05) than those who gave birth after 30 years of age .
It has been suggested that breast Our results indicated that parity, age at first delivery, and breast feeding had no effect on the BC risk.
In the preset study, the frequency of BRCA1 (185delAG) mutation was 10% among the patients. This is similar to that reported by Santrosa et al., (24) mutation were below 40 years (2/25; 8%).
Several studies found frequencies of 3.5% ,6.7% , 9%, and 20% (26) (27) (28) (29) in the patients below 40 years of age . In the present study the other 2 patients carried the mutation were above 40 years (2/15; 13.5%) at the age of onset of the disease.
Other studies reported frequencies of 1.9% (26) and 2% (27) patients with unilateral breast cancer were found to have the mutation. Steinmann et al., (31) found that the frequency of the mutation was not different between the unilateral and bilateral BC patients and explained the development of bilateral BC to familial aggregation of additional susceptibility factors modifying the penetrance of BRCA1 mutation. Other studies reported a mutation frequency of 20% (32) to 100% (33) (39) (40%).
Our results indicated that a considerable proportion of the familial risk of BC is attributable to genes other than BRCA1(185delAG) mutation.
In conclusion, our results indicated that BRCA1 (185delAG) mutation has a role in breast caner but a considerable proportion of the early breast cancer and familial breast cancer may be due to genes other than BRCA1 (185delAG) mutation. Also, bilateral breast cancer and breast ovarian cancer patients were likely of having the mutation than unilateral breast cancer patients .
